1 / 7

China Bioprocess Instruments Market: Growth, Size, Trends and Forecast to 2024

The China Bioprocess Instruments Market is expected to reach USD 3.06 billion by 2024, driven by the improving economy, aging population, and increasing prevalence of chronic diseases. Browse the report for detailed analysis and trends.

jricks
Download Presentation

China Bioprocess Instruments Market: Growth, Size, Trends and Forecast to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Your Catalyst To a Lucrative Business China Bioprocess Instruments MarketShare, Size, Analysis, Growth,Strategies,TrendsandForecaststo2024 | HexaResearch "ChinaBioprocessInstrumentsMarketWorthUSD3.06BillionBy2024" TheChinaBioprocessInstrumentsMarkets expectedtoreachUSD3.06billionby2024owingtotheimprovingeconomy,risingagingpopulationandincreasingprevalenceofchronicdiseases.Moreover,increasingdemandforsingle-useinstrumentsindisposableapplicationsisanticipatedtoaugmentthegrowthover theprojectedperiod. Chinawasthesecondlargestpharmaceuticalmarketintheworld,expectedtogrowUSD173billionby2024,growingataCAGRof9.1%owingtotherequirementofmedication&drugstocuredeadlydiseases.Hugeinvestmentinbiotechnologywillprimarilydrivethegrowthofthemarket,aspharmacompaniesdealininnovationsfordevelopingmedicinesanddrugsin linewiththeincreasing prevalenceofdiseases. Browse Details of Report @ https://www.hexaresearch.com/research-report/china-bioprocess-instruments-market Follow Us:

  2. Your Catalyst To a Lucrative Business Withthepatentsofnumerousbiopharmaceuticalproductsexpiringby2016,themarketisanticipatedto providealucrativeopportunityforcontractmanufacturersoperatingintheregion.Approvalofthetrailplan fornewdrugmarketingauthorizationholder (MAH)in2016to produce,conductclinicaltrials,andmarkettheproductsisexpected toprovideanimpetustothegrowthof theindustryoverthenext fewyears. Increasingdemandforbioprocessinstrumentsinthepharmaceutical,research&development,industrialandmedicallaboratoriescoupledwiththeincreasingnumberofthesefacilitiesisexpected toresultin thegrowthofthemarket.Changeinlifestyle&foodconsuminghabits,andgrowinglevelsofair&waterpollutionhaveledtoincreasingoccurrenceofdiseaseincludingobesitywhichhasresultedinarisingnumberofpatientsdiagnosedwithcancer,heartdisease,diabetesandotherchronicconditions.Thus,thehealthcaresectorisanticipatedtocreatedemandfortreatmentandlaboratoryservices,whichwillresultinthegrowthofbioprocessinstrumentsmarket overtheforecastperiod. Stringentregulatorypoliciesandthehighcostofinstrumentsarelikely torestrainthebioprocessinstrumentsmarketinChina.Thegovernmenthasbeenfocusingonreducingthefragmentationintheindustrybyconsolidatingmanufacturersthatlackstandardsinproductionwithlargercompanies.Thismovewillhelpinpreventingthequalityrisksandsub-parmanufacturersenteringthemarket.Shortageofskilledlaborisanotherchallengein thegrowthofbioprocessing industry. KoninklijkePhilipsN.V.,ThermoFisherScientificInc.andBecton,DickinsonandCompanywerethetopthreecompaniesinthemarketinChinain2016.Companies are extensivelyinvestinginR&Dforinnovationandnewproductdevelopment.Inaddition,companiesareadoptingthestrategyofmergerandacquisitiontoexpandtheirproductportfolio. Hexa Researchhas segmentedtheChina bioprocessinstruments market basedon type: Segmentationbytype,2014-2024(USDMillion) •CellExpansion •FlowCytometry •BiologicsSafety Testing •CellLineDevelopment •TangentialFlowFiltration •CellCounters •VirusFiltration •CellCulture •PyrogenTesting •Single-UseBioprocessing Browse Related Category Market Reports @ https://www.hexaresearch.com/research- category/pharmaceuticals-industry Follow Us:

  3. Your Catalyst To a Lucrative Business TableofContent ofChinaBioprocess Instruments Market Chapter1MarketSummary 1.1Markettrends&movement Chapter2BioprocessInstruments Market Trends: Drivers &Opportunities 2.1Introduction 2.2Keyindustry trends 2.3Marketdriveranalysis 2.3.1Risingprevalenceofchronicdiseases 2.3.2Growthin R&Dactivitiesin biopharmaceuticalindustry andlifesciences 2.3.3Marketrestraint 2.3.4Stringentregulatorypolicies 2.4Valuechain analysis 2.5SWOT 2.6Porter’sFiveForces’analysis Chapter3BioprocessInstruments Market,ByType 3.1Bioprocessinstrumentsmarket movement,bytype,2016 &2024 3.2CellExpansion 3.2.1Marketestimatesandforecast, 2014-2024(USDMillion) 3.3FlowCytometry 3.3.1Marketestimatesandforecast,2014-2024(USDMillion) 3.4BiologicalSafety Testing 3.4.1Marketestimatesandforecast, 2014-2024(USDMillion) 3.5CellLineDevelopment 3.5.1Marketestimatesandforecast, 2014-2024(USDMillion) 3.6TangentialFlowFiltration 3.6.1Marketestimatesandforecast, 2014-2024(USDMillion) 3.7CellCounter 3.7.1Marketestimatesandforecast, 2014-2024(USDMillion) 3.8CellCulture 3.8.1Marketestimatesandforecast, 2014-2024(USDMillion) 3.9PyrogenTesting 3.9.1Marketestimatesandforecast, 2014-2024(USDMillion) Follow Us:

  4. Your Catalyst To a Lucrative Business 3.10SingleUseBioprocessing 3.10.1Marketestimatesand forecast, 2014-2024(USDMillion) 3.11VirusFiltration 3.11.1Marketestimatesand forecast, 2014-2024(USDMillion) Chapter4Competitive Landscape 4.1Competitivelandscapeanalysis, 2016 4.2Strategicframework 4.3Potentialcustomerbase 4.4Company market positioning 4.5Company profiles 4.5.1Abbott 4.5.1.1Company Overview 4.5.1.2Financialperformance 4.5.1.3Productbenchmarking 4.5.1.4RecentInitiatives 4.5.2ThermoFisher ScientificInc. 4.5.2.1Company Overview 4.5.2.2Productbenchmarking 4.5.2.3Financialperformance 4.5.2.4RecentInitiatives 4.5.3AlereInc. 4.5.3.1Company overview 4.5.3.2Productbenchmarking 4.5.3.3Financialperformance 4.5.3.4RecentInitiatives 4.5.4Becton,DickinsonandCompany (BD) 4.5.4.1Company Overview 4.5.4.2Productbenchmarking 4.5.4.3Financialperformance 4.5.4.4RecentInitiatives 4.5.5KoninklijkePhilipsN.V. 4.5.5.1Company Overview 4.5.5.2Productbenchmarking 4.5.5.3Financialperformance Follow Us:

  5. Your Catalyst To a Lucrative Business 4.5.5.4RecentInitiatives 4.5.6PerkinElmer,Inc. 4.5.6.1Company overview 4.5.6.2Financialperformance 4.5.6.3Productbenchmarking 4.5.6.4RecentInitiatives 4.5.7Danaher 4.5.7.1Company Overview 4.5.7.2Financialperformance 4.5.7.3RecentInitiatives 4.5.8SHIMADZUCORPORATION 4.5.8.1Company overview 4.5.8.2Financialperformance 4.5.8.3Productbenchmarking 4.5.8.4RecentInitiatives 4.5.9CESCOBIOENGINEERINGCO.,LTD 4.5.9.1Company overview 4.5.9.2Productbenchmarking 4.5.10ShanghaiRITAI medicineequipment projectco., ltd 4.5.10.1Company overview 4.5.10.2Productbenchmarking 4.6List ofOther Vendors Chapter5MethodologyandScope 5.1ResearchMethodology 5.2Research Scope&Assumptions 5.3List ofDataSources Follow Us:

  6. Your Catalyst To a Lucrative Business AboutUs: HexaResearchisamarketresearchandconsultingorganization,offeringindustryreports,customresearchandconsultingservicestoahostofkeyindustriesacrosstheglobe.Weoffercomprehensivebusinessintelligenceintheformofindustryreportswhichhelpourclientsobtainclarityabouttheirbusinessenvironmentandenablethemtoundertakestrategicgrowth initiatives. Contact Us: RyanShaw Hexa Research FeltonOfficePlaza 6265Highway9 Felton,California95018 United States Phone: +1-800-489-3075 Email:sales@hexaresearch.com Website-https://www.hexaresearch.com/ Follow Us:

More Related